The standardized mortality rate for pancreas malignant neoplasms in Brazil shows a steady upward trend, increasing from 10.4 deaths per 100,000 persons in 2024 to an expected 11.4 by 2028. This represents a 1.9% increase from 2024 to 2025, 1.87% from 2025 to 2026, 1.83% from 2026 to 2027, and 2.70% from 2027 to 2028. The compound annual growth rate (CAGR) over the five-year forecast period is approximately 2.35%, indicating a consistent rise in mortality.
Future trends to watch include:
- Potential impacts from advancements in early detection and treatment, which may alter projected mortality rates.
- Changes in lifestyle factors and public health policies influencing cancer incidence.
- Emerging research in genetic and environmental factors contributing to pancreatic cancer.
